Operator profileNew York, USA

Click Therapeutics

Click Therapeutics appears in 2 markets tracked by Meridian Consensus across 1 industry (Healthcare). Aggregate market exposure is $55.8B, computed as the sum of (share × market size) across every appearance.

Its strongest position is United States Digital Cognitive Assessment and Digital Therapeutics Market at 1.2% share in a market growing at 5.0% CAGR. Average share across all tracked markets is 1.1%, indicating a diversified participant footprint.

Each market page below carries the full Porter Five Forces, SWOT, regional sub-data, regulatory landscape, and competitor table the operator competes against. Use the related-operator rail at the bottom of the page to triangulate Click Therapeutics against the peers it actually overlaps with in those segments.

Markets tracked

Industries

Aggregate exposure

$55.8B

Sector revenue

$55.8B

Market positions

Avg share 1.1% · sorted by exposure

Market	Industry	Market size	CAGR	Share	Revenue	Exposure
United States Digital Cognitive Assessment and Digital Therapeutics Market	Healthcare	$4537.9B	5.0%	1.2%

Explore adjacent markets

Each market page surfaces Porter Five Forces, SWOT, country analysis, patent filings, regulatory signals, and more, verified against SEC filings, FRED macro series, and trade-association benchmarks.

United States Digital Cognitive Assessment and Digital Therapeutics South Korea Digital Cognitive Assessment and Digital Therapeutics

Operators that compete with Click Therapeutics

Peers that show up alongside Click Therapeutics in the markets above. Ordered by how many overlapping markets they share — the top of the list is who the operator competes against most directly.